Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
initiating adaptive immune responses
First preclinical results of a phase I study with a LYPD3-directed antibody-drug conjugate in non-small cell lung cancer showed a sufficient antitumor efficacy in in vivo models
which is difficult to be applied to the screening and early diagnosis of malignant tumors
CD99 is ofen expressed on myeloid and lymphoid leukemia cells and can both aid in leukemia diagnosis and correlate with prognosis [PMID: 27764235
Serine/threonine protein kinase IKBKB
PE Rabbit Anti-Human CD14 Antibody (S-395-8) Viral Protein initiating adaptive immune responsesProduct Specification Host Rabbit Antigen CD14 Synonyms Monocyte differentiation antigen CD14; My23 antigen; Myeloid cell specific leucine rich glycoprotein Immunogen Synthetic Peptide Location Secreted, Cell membrane Accession P08571 Clone Number S 395 8 Antibody Type Recombinant mAb Isotype IgG Application FCM Reactivity Hu Positive Sample human peripheral blood cells Purification Protein A Concentration 0. 02mg ml Conjugation PE Physical Appearance